E
BioAtla, Inc. BCAB
$0.356 -$0.0002-0.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -59.52M -61.88M -69.78M -81.82M -104.56M
Total Depreciation and Amortization 754.00K 868.00K 925.00K 1.07M 1.11M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 4.76M 5.58M 8.11M 9.73M 11.05M
Change in Net Operating Assets 1.68M -1.97M -11.20M -14.05M -14.89M
Cash from Operations -52.32M -57.40M -71.94M -85.08M -107.29M
Capital Expenditure -- -- -- -8.00K -33.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -8.00K -33.00K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 9.36M 9.56M 9.56M 393.00K 407.00K
Repurchase of Common Stock -48.00K -62.00K -46.00K -76.00K -117.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -444.00K -366.00K -- -- --
Cash from Financing 8.87M 9.13M 9.51M 317.00K 290.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -43.46M -48.27M -62.43M -84.77M -107.03M